At present, Amicus Therapeutics Inc (FOLD) has a stock price of $7.19. In the previous session, the stock saw a rise, peaking at $22.0 after an opening price of $7.19. The day’s lowest price was $9.0, and it closed at $6.98.
The market performance of Amicus Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $12.65 on 11/06/24, while the lowest value for the same duration was $5.51 on 06/25/25.
52-week price history of FOLD Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Amicus Therapeutics Inc’s current trading price is -43.16% away from its 52-week high, while its distance from the 52-week low is 30.49%. The stock’s price range during the 52-week period has remained between $5.51 and $12.65. In the Healthcare sector, the company’s shares saw a trading volume of around 6.82 million for the day, which was evidently higher than the average daily volume of 4.72 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Amicus Therapeutics Inc (FOLD) has experienced a quarterly rise of 19.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.22B and boasts a workforce of 499 employees.
A Closer Look at Analysts’ Ratings for Amicus Therapeutics Inc
As of right now, 8 analysts are rating Amicus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.56, with a change in price of -1.89. Similarly, Amicus Therapeutics Inc recorded 4,729,969 in trading volume during the last 100 days, posting a change of -20.81%.
Examining FOLD’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for FOLD stands at 2.17. Similarly, the long-term debt-to-equity ratio is also 2.13.
FOLD Stock Stochastic Average
Amicus Therapeutics Inc’s raw stochastic average for the past 50 days is presently 94.92%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 93.41%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 83.81% and 77.79%, respectively.
FOLD Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -37.37%.However, over the last six months, we can see a stronger performance of -24.87%. Over the last 30 days, the price of FOLD has fallen by 21.66%. And in the last five days, it has surged by 3.75%.
